TRIFLURIDINE/TIPIRACIL (FTD/TPI) with or without bevacizumab in previously treated patients with esophago-gastric adenocarcinoma, a randomised phase III trial.
Saved in:
| Title: | TRIFLURIDINE/TIPIRACIL (FTD/TPI) with or without bevacizumab in previously treated patients with esophago-gastric adenocarcinoma, a randomised phase III trial. |
|---|---|
| Authors: | Baeksgaard Jensen L; Department of Oncology, Rigshospitalet, Copenhagen, Denmark., Yilmaz M; Department of Oncology and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark., Nordsmark M; Department of Oncology, Aarhus University Hospital, Denmark., Möller S; Odense Patient Data Explorative Network (OPEN), Odense University Hospital, Denmark., Elle IC; Department of Oncology, Odense University Hospital, Denmark., Ladekarl M; Department of Oncology and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., Qvortrup C; Department of Oncology, Rigshospitalet, Copenhagen, Denmark., Pfeiffer P; Department of Oncology, Odense University Hospital, Denmark. |
| Source: | EClinicalMedicine [EClinicalMedicine] 2024 Mar 08; Vol. 70, pp. 102521. Date of Electronic Publication: 2024 Mar 08 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38495525 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: TRIFLURIDINE/TIPIRACIL (FTD/TPI) with or without bevacizumab in previously treated patients with esophago-gastric adenocarcinoma, a randomised phase III trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Baeksgaard+Jensen+L%22">Baeksgaard Jensen L</searchLink>; Department of Oncology, Rigshospitalet, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Yilmaz+M%22">Yilmaz M</searchLink>; Department of Oncology and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Nordsmark+M%22">Nordsmark M</searchLink>; Department of Oncology, Aarhus University Hospital, Denmark.<br /><searchLink fieldCode="AU" term="%22Möller+S%22">Möller S</searchLink>; Odense Patient Data Explorative Network (OPEN), Odense University Hospital, Denmark.<br /><searchLink fieldCode="AU" term="%22Elle+IC%22">Elle IC</searchLink>; Department of Oncology, Odense University Hospital, Denmark.<br /><searchLink fieldCode="AU" term="%22Ladekarl+M%22">Ladekarl M</searchLink>; Department of Oncology and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Qvortrup+C%22">Qvortrup C</searchLink>; Department of Oncology, Rigshospitalet, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Pfeiffer+P%22">Pfeiffer P</searchLink>; Department of Oncology, Odense University Hospital, Denmark. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101733727%22">EClinicalMedicine</searchLink> [EClinicalMedicine] 2024 Mar 08; Vol. 70, pp. 102521. <i>Date of Electronic Publication: </i>2024 Mar 08 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22The+Lancet%22">The Lancet </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101733727 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2589-5370 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225895370%22">25895370 </searchLink><i>NLM ISO Abbreviation: </i>EClinicalMedicine <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38495525 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.eclinm.2024.102521 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 102521 Titles: – TitleFull: TRIFLURIDINE/TIPIRACIL (FTD/TPI) with or without bevacizumab in previously treated patients with esophago-gastric adenocarcinoma, a randomised phase III trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Baeksgaard Jensen L – PersonEntity: Name: NameFull: Yilmaz M – PersonEntity: Name: NameFull: Nordsmark M – PersonEntity: Name: NameFull: Möller S – PersonEntity: Name: NameFull: Elle IC – PersonEntity: Name: NameFull: Ladekarl M – PersonEntity: Name: NameFull: Qvortrup C – PersonEntity: Name: NameFull: Pfeiffer P IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 03 Text: 2024 Mar 08 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2589-5370 Numbering: – Type: volume Value: 70 Titles: – TitleFull: EClinicalMedicine Type: main |
| ResultId | 1 |